Plain-English translation of NCT07552454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new medication called to treat a skin condition called palmoplantar pustulosis, which causes painful pustules (small, pus-filled bumps) on the palms of your hands and soles of your feet. The trial will enroll 60 people who have already tried other standard treatments without success. Researchers want to see whether this medication is safe and effective for this condition.
Palmoplantar pustulosis can be stubborn and difficult to treat—some people don't respond well to standard medications or can't tolerate their side effects. This trial exists to find out whether this medication could offer a better option for people who haven't had luck with existing treatments.
You likely qualify if…
You likely don't qualify if…
You would take the new medication as prescribed by the research team at the hospital dermatology department. Throughout the study, you would attend follow-up visits so doctors can check how well the medication is working and monitor for any side effects. The exact duration and visit schedule aren't specified in the trial details, but your doctor will explain the full timeline and requirements when you enroll.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China